We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$709M
AUM Growth
+$35.5M
Cap. Flow
+$8.06M
Cap. Flow %
1.14%
Top 10 Hldgs %
29.88%
Holding
142
New
3
Increased
59
Reduced
43
Closed
2

Top Buys

Rank Stock Value
1
CBRL icon
Cracker Barrel
CBRL
+$3.07M
2
VMC icon
Vulcan Materials
VMC
+$2.89M
3
TFC icon
Truist Financial
TFC
+$2.4M
4
MSFT icon
Microsoft
MSFT
+$2.16M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$891K

Top Sells

Rank Stock Value
1
PNY
PIEDMONT NATURAL GAS CO INC(NC
PNY
+$3.66M
2
JCI icon
Johnson Controls International
JCI
+$1.57M
3
APD icon
Air Products & Chemicals
APD
+$794K
4
WFC icon
Wells Fargo
WFC
+$541K
5
GLD icon
SPDR Gold Trust
GLD
+$514K

Sector Composition

Rank Sector Weight
1 Industrials 20.74%
2 Consumer Staples 10.68%
3 Financials 10.07%
4 Healthcare 9.8%
5 Consumer Discretionary 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFL icon
126
Aflac
AFL
$63.9B
$251K 0.04%
7,204
+220
+3% +$7.75K
QCOM icon
127
Qualcomm
QCOM
$176B
$242K 0.03%
3,708
+714
+24% +$48K
K
128
DELISTED
Kellanova
K
$235K 0.03%
3,402
+100
+3% +$6.95K
ED icon
129
Consolidated Edison
ED
$41.6B
$215K 0.03%
2,921
+1
+0% +$72
TTE icon
130
TotalEnergies
TTE
$193B
$204K 0.03%
+4,000
New +$193K
EOG icon
131
EOG Resources
EOG
$78B
$202K 0.03%
+2,000
New +$195K
PRA
132
DELISTED
ProAssurance
PRA
$202K 0.03%
+3,600
New +$199K
POT
133
DELISTED
Potash Corp Of Saskatchewan
POT
$197K 0.03%
10,900
– –
OPK icon
134
Opko Health
OPK
$921M
$169K 0.02%
18,119
– –
AMLP icon
135
Alerian MLP ETF
AMLP
$13B
$151K 0.02%
2,400
-2,100
-47% -$130K
NVIV
136
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$126K 0.02%
2
– –
NWBO
137
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$87K 0.01%
249,625
– –
NCV
138
Virtus Convertible & Income Fund
NCV
$374M
$85K 0.01%
3,350
– –
GNMX
139
DELISTED
Aevi Genomic Medicine Inc
GNMX
$78K 0.01%
15,143
– –
SONN
140
DELISTED
Sonnet BioTherapeutics
SONN
– –
0
– –
VLY icon
141
Valley National Bancorp
VLY
$7.93B
– –
-12,132
Closed -$118K
PNY
142
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
– –
-60,900
Closed -$3.66M
2 3 4 5
6

Similar funds

AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Charles D. Hyman's Q4 2016 Portfolio in Review

As of Q4 2016, Charles D. Hyman held 142 positions worth $709M, up 5.3% from $674M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 3.5%. Charles D. Hyman opened 3 new positions and exited 2, leaving the 142-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.

  • Charles D. Hyman's largest Q4 2016 buy was ProAssurance: 3,600 shares worth $202K.
  • Charles D. Hyman added most to Cracker Barrel in Q4 2016, an estimated $3.07M increase.
  • Charles D. Hyman's biggest Q4 2016 reduction was Johnson Controls International, cutting an estimated $1.57M.
  • Charles D. Hyman fully exited PIEDMONT NATURAL GAS CO INC(NC in Q4 2016, selling an estimated $3.66M.
  • Charles D. Hyman's ten largest holdings make up 30% of its $709M portfolio in Q4 2016.
  • Charles D. Hyman opened 3 new positions and closed 2 in Q4 2016.
  • Charles D. Hyman's portfolio value rose 5.3% quarter-over-quarter to $709M.

Based on Charles D. Hyman's 13F filing for Q4 2016, filed 8 Feb 2017.